Utama › Skizofrenia › Maryland
Kajian klinikal Skizofrenia di Maryland
18 kajian untuk Skizofrenia sedang mencari peserta di lokasi di Maryland.
Bandar di Maryland
Teks kajian rasmi (Bahasa Inggeris)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- University of Maryland, Baltimore, Baltimore
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 59 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07853807Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- The Johns Hopkins Hospital, Baltimore
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07101094Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0192, Gaithersburg
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07114874A Study of Brenipatide in Adult Participants With Schizophrenia
- CBH Health, Gaithersburg
Mengambil pesertaFasa 2
Umur 18 hingga 55 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07410507A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CBH Health LLC., dba CenExel Gaithersburg MD, Gaithersburg
Mengambil pesertaFasa 1
Umur 18 hingga 55 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Cbh Health - Gaithersburg /ID# 272932, Gaithersburg
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- CenExel Gaithersburg, Gaithersburg
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Gaithersburg
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07459647A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel CBH, Gaithersburg
Mengambil pesertaFasa 2
Umur 18 hingga 55 · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07191483Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of Maryland School of Medicine, Baltimore
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05208190Synbiotic Compound to Reduce Symptoms of Schizophrenia
- Sheppard Pratt Health System, Batlimore
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 7 Apr 2026 · NCT04226898NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 6 Mac 2026 · NCT06963034White Matter Plasticity in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
- University of Maryland Baltimore - Maryland Psychiatric Research Center, Catonsville
Mengambil peserta
Umur 15 hingga 45 · Semua jantina · Dikemas kini 20 Feb 2026 · NCT06641297TMS for Inhibition Enhancement in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
Mengambil peserta
Umur 18 hingga 45 · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06155682CBT-CP for Veterans With SMI
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Feb 2026 · NCT06758414Study of ALTO-101 in Patients With Schizophrenia
- Site 5062, Gaithersburg
Mengambil pesertaFasa 2
Umur 21 hingga 55 · Semua jantina · Dikemas kini 26 Dis 2025 · NCT06502964Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Gaithersburg
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 19 Dis 2024 · NCT05184335Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.